Related Experiment Video
Updated: Aug 11, 2026

5/6th Nephrectomy in Combination with High Salt Diet and Nitric Oxide Synthase Inhibition to Induce Chronic Kidney Disease in the Lewis Rat
Published on: July 3, 2013
A multicenter, randomized, double-blind, placebo-controlled, two-year trial to study the effect of nitrendipine on
M Barenbrock1, U Colmorgen, E Firschka
1Department of Medicine, University of Berlin (Charité), Germany.
Abstract:
The ongoing multicenter, randomized, double-blind, placebo-controlled trial investigates the effect of nitrendipine on kidney function after renal transplantation. Renal transplant recipients (6th-12th postoperative week, serum creatinine < 3 mg/dl) were divided into a normotensive (diastolic blood pressure < 90 mmHg) and a hypertensive group (diastolic blood pressure > or = 90, < 115 mmHg). Normotensive patients are randomly treated for 104 weeks with nitrendipine 2 x 5 mg daily or placebo, hypertensive patients with 2 x 10 mg - 2 x 20 mg nitrendipine daily or placebo and in case of inefficacy with additional antihypertensive drugs. Primary end point of the study is the renal transplant function. The trial was started in June 1990. One hundred and eight patients were included into the normotensive and 138 patients into the hypertensive group. Renal allograft function, cyclosporine trough levels and the donor characteristics were not different between the normotensive and hypertensive groups at entry into the study. After 12 months there was no significant change of renal transplant function in both groups. Cyclosporine trough levels were also similar in the normotensive and hypertensive group after 12 months. As expected, blood pressure decreased significantly after 12 months from 150 +/- 17/95 +/- 11 mmHg to 141 +/- 16/90 +/- 9 mmHg in the hypertensive group (p < 0.01). In contrast, in the normotensive group blood pressure increased significantly from 128 +/- 12/80 +/- 6 mmHg to 135 +/- 15/86 +/- 8 mmHg (p < 0.001). No normotensive but 4 hypertensive patients developed graft failure during the first 12 months of the study.
Insights
Nitrendipine did not significantly alter kidney function in renal transplant recipients. However, it effectively lowered blood pressure in hypertensive patients, while normotensive patients experienced a rise in blood pressure.
Area of Science:
- Nephrology
- Transplantation Immunology
- Pharmacology
Background:
- Renal transplantation is a critical treatment for end-stage renal disease.
- Maintaining optimal blood pressure is crucial for graft survival post-transplantation.
- The role of specific antihypertensive agents like nitrendipine in renal transplant recipients requires further investigation.
Purpose of the Study:
- To evaluate the effect of nitrendipine on kidney function in renal transplant recipients.
- To assess the impact of nitrendipine on blood pressure control in both normotensive and hypertensive transplant patients.
- To determine the incidence of graft failure in relation to nitrendipine treatment.
Main Methods:
- A multicenter, randomized, double-blind, placebo-controlled trial was conducted.
- Renal transplant recipients were stratified into normotensive and hypertensive groups.
- Patients received either nitrendipine or placebo for 104 weeks, with additional antihypertensives used if necessary.
Main Results:
- No significant changes in renal transplant function were observed in either group after 12 months.
- Nitrendipine significantly decreased blood pressure in the hypertensive group.
- Blood pressure increased significantly in the normotensive group treated with nitrendipine.
- Graft failure occurred in 4 hypertensive patients but none in the normotensive group.
Conclusions:
- Nitrendipine does not appear to significantly impact renal transplant function in the short term.
- Careful blood pressure monitoring is essential in renal transplant recipients, particularly when using nitrendipine in normotensive individuals.
- Further research is needed to understand the long-term effects and optimal use of nitrendipine in this population.
Related Concept Videos
Antihypertensive Drugs: Direct Renin Inhibitors
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Continuous Renal Replacement Therapy
Kidney Transplant I: Introduction
Kidney Transplant II: Surgical Procedure
Kidney Transplant III: Nursing Management

